[Comparison of etilefrin hydrochloride (not sustained-action) and etilefrin hydrochloride sustained-action pellets in a crossover trial in humans. Investigation of absorption time, absorption rate, blood levels and half-life].
D002214:Capsules; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005039:Etilefrine / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D006207:Half-Life; D006801:Humans; D007408:Intestinal Absorption; D007700:Kinetics; D008297:Male; D010656:Phenylephrine / Q000031:analogs & derivatives*
D002214:Capsules; D003692:Delayed-Action Preparations; D010656:Phenylephrine; D005039:Etilefrine
Vergleich von Etilefrin-hydrochlorid (nicht retardiert) und Etilefrin-hydrochlorid in Retard-Pellets im Cross-over-Versuch am Menschen. Untersuchung der Resorptionsgeschwindigkeit, Resorptionsrate, Blutspiegel und biologischen Halbwertszeit.